Literature DB >> 14966210

Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C alpha.

Christopher Kerfoot1, Weidong Huang, Susan A Rotenberg.   

Abstract

Forty-six advanced-stage human breast carcinoma specimens were evaluated by immunohistochemistry for PKC alpha expression and compared with 25 samples of normal adjacent breast tissue. For normal tissue, the median staining of ductal epithelia was of moderate intensity. No staining was observed for 67% of tumor specimens, and only 4% showed intensities greater than the median observed in normal tissue. Faint to moderate PKC alpha staining was observed in the stroma, inflammatory cells, and fibroblasts of tumors but was absent in normal tissue. These findings demonstrate that downregulation of PKC alpha protein occurs in epithelial cells of advanced breast tumors (p<0.001).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966210     DOI: 10.1177/002215540405200314

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  28 in total

1.  A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer.

Authors:  David S Hong; Razelle Kurzrock; Yun Oh; Jennifer Wheler; Aung Naing; Les Brail; Sophie Callies; Valérie André; Sunil K Kadam; Aejaz Nasir; Timothy R Holzer; Funda Meric-Bernstam; Mayer Fishman; George Simon
Journal:  Clin Cancer Res       Date:  2011-08-10       Impact factor: 12.531

2.  Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.

Authors:  Elham Kalantari; Mojgan Asgari; Seyedehmoozhan Nikpanah; Naghme Salarieh; Mohammad Hossein Asadi Lari; Zahra Madjd
Journal:  Pathol Oncol Res       Date:  2017-01-12       Impact factor: 3.201

3.  Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.

Authors:  Biao Wu; Hong Zhou; Lichao Hu; Yuan Mu; Ying Wu
Journal:  Tumour Biol       Date:  2012-12-12

4.  PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance.

Authors:  Kinnari Pandya; Debra Wyatt; Brian Gallagher; Deep Shah; Andrew Baker; Jeffrey Bloodworth; Andrei Zlobin; Antonio Pannuti; Andrew Green; Ian O Ellis; Aleksandra Filipovic; Jason Sagert; Ajay Rana; Kathy S Albain; Lucio Miele; Mitchell F Denning; Clodia Osipo
Journal:  Clin Cancer Res       Date:  2015-09-08       Impact factor: 12.531

5.  Cisplatin and TRAIL enhance breast cancer stem cell death.

Authors:  Shuping Yin; Liping Xu; Sudeshna Bandyopadhyay; Seema Sethi; Kaladhar B Reddy
Journal:  Int J Oncol       Date:  2011-06-16       Impact factor: 5.650

6.  PKCalpha expression is a marker for breast cancer aggressiveness.

Authors:  Gry Kalstad Lønne; Louise Cornmark; Iris Omanovic Zahirovic; Göran Landberg; Karin Jirström; Christer Larsson
Journal:  Mol Cancer       Date:  2010-04-14       Impact factor: 27.401

7.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

8.  Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis.

Authors:  Daisuke Hoshino; Jerome Jourquin; Shane Weller Emmons; Tyne Miller; Margalit Goldgof; Kaitlin Costello; Darren R Tyson; Brandee Brown; Yiling Lu; Nagendra K Prasad; Bing Zhang; Gordon B Mills; Wendell G Yarbrough; Vito Quaranta; Motoharu Seiki; Alissa M Weaver
Journal:  Sci Signal       Date:  2012-09-11       Impact factor: 8.192

9.  Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.

Authors:  J W Assender; J M W Gee; I Lewis; I O Ellis; J F R Robertson; R I Nicholson
Journal:  J Clin Pathol       Date:  2007-11       Impact factor: 3.411

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.